Tussal Expectorans for acute and chronic respiratory diseases. Composition and dosage of the drug

Tussal Expectorans is used in acute and chronic respiratory diseases with abnormal, excessively thick secretions. The preparation dilutes secretions and removes them from the respiratory tract. The active substance of the drug is ambroxol, which, through its action, reduces the viscosity of the mucus and thins it, which leads to its easier transport from the respiratory tract. The drug is in the form of tablets for oral administration and is dispensed without a prescription.

Tussal Expectorans (Biofarm)

form, dose, packaging availability category the active substance
tabl. 0,03 g (10 tabl.) OTC (over-the-counter) ambroxol (ambroxol)

ACTION

Mukolityk

Tussal Expectorans – indications and dosage

Tussal Expectorans is intended for use in acute and chronic respiratory diseases with abnormal, excessively thick secretions:

  1. acute and chronic bronchitis or pneumonia,
  2. bronchial asthma,
  3. emphysema,
  4. cystic fibrosis.

Drug dosage

Tussal Expectorans is in the form of tablets and is intended for oral use. Take the capsules with a drink of water after a meal. Avoid taking the drug at bedtime. Do not exceed the recommended dose of the preparation as it may pose a threat to your life or health.

  1. Adults and children over 12 years of age. Initially 30 mg three times a day for 3-2 days, then 3 mg twice a day.
  2. Children 6-12. age. 15 mg 2-3 × / day.

Tussal Expectorans and contraindications

Contraindications to taking Tussal Expectorans are:

  1. hypersensitivity to any component of the preparation,
  2. use in children up to the age of 6.

Tussal Expectorans – warnings

  1. Particular caution is recommended in patients with gastric or duodenal ulcer disease, with hepatic failure, with renal failure – in these patients, medical consultation and consideration of reducing the daily dose or extending the intervals between doses is recommended.
  2. Tussal Expectorans should be taken with particular caution in people who have a weakened cough reflex or impaired ciliary clearance of the bronchi, as there may be a risk of retention of secretions.
  3. Antitussive drugs should not be used simultaneously with the preparation.
  4. In the initial phase of treatment with the drug, an excessive amount of liquid bronchial secretion may appear. In such a situation it is recommended to provoke a cough in order to cough up the thin secretion or to suck it out.
  5. Patients with bronchial asthma are at risk of severe coughing and excessive expectoration at the beginning of taking the drug.
  6. Treatment should be discontinued and a doctor should be consulted immediately if changes appear on the skin or mucous membranes, as there is a risk of severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis).
  7. Tussal Expectorans contains lactose.
  8. People with hereditary problems of galactose intolerance, the lactase deficiency or glucose-galactose malabsorption should not take the preparation.
  9. Pregnant and breastfeeding women may take the drug only after consulting a doctor and if absolutely necessary, when the doctor decides that the benefit for the mother outweighs the potential risk for the child.

Tussal Expectorans with other drugs

  1. Antitussive drugs should not be taken with the preparation, as it helps to remove a large amount of the secretion produced.
  2. Ambroxol and theophylline intensify each other’s effects.
  3. Taking the preparation with antibiotics: amoxicillin, cefuroxime, doxycycline, erythromycin increases their penetration into the lung tissue and intensifies their effect.

Tussal Expectorans – Side Effects

Taking Tussal Expectorans may cause the following side effects:

  1. stomach pain,
  2. nausea and constipation
  3. heartburn,
  4. vomiting,
  5. indigestion,
  6. hypersensitivity reactions such as rash, itching, breathing problems,
  7. anaphylactic reactions such as face swelling, shortness of breath, temperature increase, anaphylactic shock,
  8. severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis).

Leave a Reply